Pulse Biosciences, Inc (PLSE)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $1.98B
- P/E ratio
- —
- EPS
- —
- Volume
- 265,694
- 52-week high
- —
- 52-week low
- —
- Open
- $28.66
- Day high
- $29.48
- Day low
- $27.43
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $350K | -$72.78M | -$1.08 |
| 2024 | $0 | -$53.59M | -$0.92 |
| 2023 | $0 | -$42.21M | -$0.85 |
| 2022 | $700K | -$58.51M | -$1.72 |
| 2021 | $1.42M | -$63.66M | -$2.28 |
About Pulse Biosciences, Inc
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
- CEO
- Paul Arthur LaViolette
- Employees
- 116
- Country
- US
- IPO date
- May 18, 2016
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Pulse Biosciences, Inc's stock price today?
- PLSE is trading at $28.96 as of Jul 20, 2026.
- What is Pulse Biosciences, Inc's market cap?
- Pulse Biosciences, Inc (PLSE) has a market capitalization of $1.98B.
- Does Pulse Biosciences, Inc pay a dividend?
- Pulse Biosciences, Inc did not pay a dividend in its most recent reported fiscal year.
- What sector is Pulse Biosciences, Inc in?
- Pulse Biosciences, Inc operates in the Healthcare sector.